This was explained by Dr. Pardis Zarifkar, lead author of the Department of Neurology, Rigshospitalet, Copenhagen, Denmark; “More than two years after the onset of the COVID-19 pandemic, the nature and precise evolution of the effects of COVID-19 on neurological disorders remained uncharacterized.
“Previous studies have established an association with neurological syndromes, but so far it is unknown whether COVID-19 also influences the incidence of specific neurological diseases and whether it differs from other respiratory infections.
“The increased risk of most neurological diseases, however, was not greater in positive patients with COVID-19 than in people who had been diagnosed with influenza or other respiratory diseases. Patients with COVID-19 had a higher risk. 1.7 times more ischemic stroke compared to patients with influenza and bacterial pneumonia over 80 years of age.
“The frequency of other neurodegenerative diseases such as multiple sclerosis, myasthenia gravis, Guillain-Barré syndrome and narcolepsy did not increase after COVID-19, influenza or pneumonia.”
READ MORE: Heart attack: five “atypical” symptoms that may appear with “months or even more” before